Introduction
The incidence and prevalence of inflammatory bowel disease (IBD) has been globally increasing, with a more pronounced growth in developing countries. 1 Although the exact pathophysiological mechanisms underlying this increase are unknown, one potential explanation could be the Western diet, with high sugar, animal protein and fat intake, especially n-6 polyunsaturated fatty acids, but less consumption of vegetables. [2] [3] [4] It is assumed that this 'Westernization' of dietary habits can trigger a pro-inflammatory environment 5 in susceptible individuals. Despite the lack of a general consensus [6] [7] [8] or robust evidence 9, 10 on what diets modulate the course of disease in IBD, a multitude of dietary recommendations have been suggested, such as the specific carbohydrate diet, low fermentable oligosaccharides, disaccharides and monosaccharides, and the Palaeolithic diet. 11 These scarce data frequently result in unnecessarily restrictive diets in IBD patients. 9 The prevalence of healthy subjects following a vegetarian diet (VD) is around 5% in the USA and in Switzerland. 12 Another important and growing population restricting intake of certain foods are healthy individuals who follow a gluten-free diet (GFD) without having coeliac disease (CeD). The prevalence of GFD without CeD in the USA in 2010 was around 0.5% 13 and reached up to 1.7% in 2014. 14 Regarding epidemiological data, a VD may have protective effects on the risk of IBD. 15 However, only a few studies have investigated the beneficial or deleterious effects of specific diets on the course of the established disease. Higher intake of meat may increase the risk of a relapse in ulcerative colitis (UC) 16 and a semi-VD could have a protective effect against relapse of Crohn's Disease (CD). 17 Nevertheless, the data are currently insufficient to recommend any specific diet.
Amongst potential modulators of dietary intake and its effect on intestinal inflammation, the intestinal microbiome is certainly a key candidate. 18 Many studies have shown a microbial dysbiosis in the gut of patients with IBD with lower diversity in their gut microbiota. 19, 20 Although it is still unclear if this dysbiosis contributes to the pathogenesis of IBD 21 or rather represents a sequel of the disease itself (the hen and egg question), several studies indicate that the former applies. 22 Changes in IBD patients' diets might promote alterations in the microbial composition, which in turn might promote beneficial effects on the course of the disease. Importantly, microbial alterations induced by dietary changes might also induce an adverse effect in terms of the development of IBD and adversely impact the course of the disease, as widely suggested by various investigators attributing the increasing incidence of IBD in developing countries to a change in environmental factors, often considered to be the outcome of 'Westernization'. 23 In this study, we aimed to test for an association of dietary restriction with a VD and GFD (two distinctive globally highly prevalent restrictive dietary habits) in the Swiss Inflammatory Bowel Disease Cohort (SIBDC), a large, prospective and comprehensive cohort study. In addition, we investigated whether mucosa-associated intestinal microbial composition differs between IBD patients based on these daily dietary habits.
Materials and methods

Study design and characteristics
We used prospectively obtained data from the physicians' and patients' baselines, and annual follow-up questionnaires from adult patients included in the SIBDC Study (SIBDCS) between 2006 and 2015. 24 In addition, we developed an additional specific questionnaire relating to the patients' diet, which was sent to all patients participating in the SIBDCS (Supplemental Questionnaire). The SIBDCS is a nationwide cohort study enrolling IBD patients in Switzerland since 2006 and is supported by the Swiss National Science Foundation. Data are collected in multiple hospitals, including smaller regional hospitals and large tertiary referral centres, as well as private practices, throughout Switzerland. All patients in the SIBDCS who returned the self-reported and annual follow-up questionnaires were included in the study. The SIBDCS has been approved by the respective ethics committees in Switzerland and the lead ethics committee, the Cantonal Ethics Committee of Zurich. The presented study is part of the research plan of the SIBDCS (number EK-1316, approved on 5 February 2007). Participants were enrolled only after they had provided written informed consent. The study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki.
Outcome measures
Clinical and disease-related factors were obtained by a physician's questionnaire.
Every patient who answered 'never' in the questionnaire to the question 'How many times a week do you eat meat' was defined as a vegetarian. We considered all patients who answered 'yes' to the question 'Are you on a gluten-free diet?' to be GFD patients.
Independent variables were used to study potential associations with diet (see Supplementary file for variables (1)).
Data analysis
Categorical data were presented as raw numbers and percentages. Differences in categorical variables distribution between two or more groups were assessed using the Chi-square test, or Fisher's exact test in case of insufficient sample size. Continuous data distribution normality was assessed using normal QQ-plots and is summarized with their median, interquartile rage (IQR) and range. Differences in continuous distributions between the two groups were assessed using the Mann-Whitney-Wilcoxon test.
Microbiota analysis of biopsies from IBD patients
A DNA extraction protocol was carried out for 213 human biopsies of 92 patients within the SIBDC using the manufacturer's instructions using an All Prep DNA/RNA Mini Kit (QIAGEN). Samples were taken alongside the lower gastrointestinal tract (within reach of standard ileocolonoscopy) starting from ileum, and incorporated three different locations in the colon and a sample from the rectum, as described in the study of Yilmaz et al. 25 There were some samples that were collected from the inflamed part based on clinician observation; however, when we analysed for microbiota differences between inflamed and non-inflamed tissue, we did not observe any substantial differences. 25 Briefly, 700 ml of buffer RLT plus b-mercaptoethanol with a metal bead were added into each sample, which were then homogenized using a Retsch Tissue Lyser (QIAGEN) at 30/frequency for 3 min, followed by 3 min centrifugation at maximum speed (Eppendorf). Supernatants were transferred to a spin column and centrifuged at 10,000 r/min for 1 min. Then, columns were washed/desalted using 500 ll of buffer AW1 and buffer AW2, before elution with 30 ll EB buffer (QIAGEN) to elute DNA into 1.5 ml microfuge tubes. Afterwards, the V5/V6 regions of the 16S rRNA genes with barcoded forward primers were sequenced using the IonTorrent Personal Genome Machine TM (PGM) platform, according to the manufacturer's instructions (Thermo Fisher Scientific).
Samples with > 4000 reads were processed for further analysis and initially clustered using the QIIME 1.9.1 pipeline. Representative operational taxonomic units (OTUs) were picked after clustering UCLUST with a 97% sequence identity threshold and followed by taxonomy assignment using the Greengenes database. Then, species richness (alpha diversity analysis; observed OTUs, Simpson and Shannon index) and microbial differences (beta diversity analysis; Bray-Curtis dissimilarities) were calculated in the phyloseq library of R (v3.4). Non-parametric MannWhitney U-tests were used to check significant differences in alpha diversity analysis and Adonis (Permanova method on distances; 9999 permutations) was used to assess the statistical significance between groups in beta diversity. A p < 0.05 was considered significant. Taxonomy profiles associated with clinical metadata were analysed using the multivariate analysis by linear models (MaAsLin) R package and plotted later using the ggplot2 library in R. With a false discovery rate (FDR) using a BenjaminiHochberg FDR correction of 0.05, taxa present 30% of the samples with >0.001% relative abundance were set as the cut-off value for significance. Significant taxa were plotted as arcsin-square roottransformed microbial relative abundances. To limit pre-analytical biases, our microbiota analysis between dietary groups were based on mucosa-associated and not faecal samples.
Results
VDs and GFDs in the SIBDCS
Of a total of 1993 patients currently enrolled in the SIBDCS, 1313 (66%) responded to the dietary questionnaire; 680 questionnaires were incomplete. We included a total of 1254 patients for the VD and 1223 for the GFD analysis. Overall, 4.1% (n ¼ 52) of the IBD patients followed a VD and 4.7% (n ¼ 57) a GFD, with median duration of 16.1 and 2.8 years, respectively (S- Figure 1A and B). Most of the glutenavoiding IBD patients (n ¼ 50, 4%) did not have a diagnosis of CeD. A vegan diet was reported by only 0.5% (n ¼ 6) of patients. Differences in diet types are seen in Table 1 and Table 2 (text in supplementary file (2)).
Amongst GFD patients, we did not observe a gender difference. Differences in GFD versus regular diet (RD) patients are demonstrated in Table 3 (text in supplementary file (3)).
Rationale for dietary restriction
In VD patients, the most frequently reported rationale underlying dietary restriction was 'respect for animals' (42.3%), while less than one in five patients reported 'benefits for my IBD' (17.3%) as the most important rationale. In contrast, the latter rationale (benefits for IBD) was the most frequently reported underlying rationale in GFD patients (40.4%; Figure 1 ).
Course of IBD
We did not find significant differences in either GFD or VD patient disease activities based on Crohn's Disease Activity Index (CDAI) and MTWAI (S- Figure 
Mucosa-associated microbiota composition in VD and GFD versus RD patients
Overall, sequences of 213 mucosa-associated samples from 92 patients were available for microbial analysis, including 14 VD (26 samples) and 12 GFD (30 samples) patient samples. Age and body mass index, both of which are known microbial composition-modifying, and thus potential cofounding, factors in these analyses were relatively evenly distributed across dietary groups (S- Figure 5 ). Within the majority of meat-eating patients ( > 95% of all SIBDCS patients), we further compared the microbiotas of the low-versus highmeat intake patients (i.e. 4 versus > 4 days per week) with regards to a potential dose-response. Alpha diversity analysis tended to be higher in GFD CD patients versus RD CD patients (p > 0.05). Within CD patients, the lowest species richness was observed in those patients eating meat > 4 days per week. In UC patients, the GFD group tended to have the lowest species richness, with a trend for the highest species richness in patients eating meat on > 4 days (S- Figure 6) .
Regarding beta diversity, we identified clustering of samples according to diet type in CD and UC patients. We calculated microbial feature differences using BrayCurtis dissimilarities on principal component analysis (PCoA) plots and statistical tests performed using Adonis (Permanova method on distances; 9999 permutations). When GFD, high-meat diets or VDs were compared, significant differences between diet types were observed in CD patients (p¼0.012; R 2 : 0.02503; Supplementary Figure 7A ) and in UC patients (p < 0.001; R 2 : 0.10771; Supplementary Figure 7B ). It should be noted that beta dispersion of these PCoA plots was > 0.05, indicating that we cannot reject the null hypothesis that our groups have the same dispersions.
Additionally, significant differences in the OTUs between diet types were seen (p < 0.05). In CD patients, several representatives of the phyla Bacteroidetes (unassigned OTUs within the genera Bacteroidales, Bacteroides and Prevotella) and Firmicutes (OTUs within the genera Clostridiales and Faecalibacterium) were significantly correlated with RD patients when compared to the GFD patients (Figure 3) . In UC patients, we identified correlation with several OTUs from Firmicutes (unassigned OTUs within Clostridiales and Ruminococcus genera) in the meat-eating groups. Within the phylum Bacteroidetes, we observed a positive correlation with Bacteroides in the meat-eating and Prevotella in the GFD group (adjusted p-value < 0.01) (Figure 3 ). Analysing potential differences of specific OTUs between meat-eating and vegetarian UC patients, we found a higher abundance of representative strains from the genera Bacteroides, Faecalibacterium and Sutturella in meat-eating patients, and a higher abundance of most representatives from the Firmicutes phylum (Blautia, Coprococcus, Ruminococcus and Dorea) in the vegetarian group ( Figure 4 ) (additional results in supplementary file (4)).
Discussion
We conducted a cross-sectional analysis in patients from the SIBDCS in order to investigate dietary restrictions, their influence on disease course and microbiota composition.
In this large investigation on the prevalence of specific diets, a total of 4.1% IBD patients followed a VD. This number of vegetarians is similar to the number in the general population of western countries and is analogous to a recently published study by Limdi et al. 26 concerning IBD patients. The main reported reason for following a VD was respect for animals, followed by an expected or perceived benefit on IBD and general health. The latter two motives appear to be Overall, a total of 4.7% of our IBD patients followed a GFD, most of whom were without a diagnosis of CeD. The 4% of IBD patients who follow a GFD without suffering from CeD in our study is double the prevalence in the general population, where the rate of GFD is approximately 2%.
14 Our findings are supported by a cross-sectional study by Herfarth et al., in which a high prevalence of GFD (8%) in IBD patients without CeD could be seen. 27 Presumably, the higher percentage of IBD patients can be explained by the belief or expectation of a favourable effect on their disease course. This is also indicated by our results regarding the reasons why patients follow a GFD.
In contrast to the beliefs of the patients, our data could not objectify an association of restrictive dietary patterns with the course of IBD. However, as an exception, we identified lower rates of complications in vegetarian CD patients. Although this was only seen in a subgroup of patients, our findings support the assumption that dietary habits could potentially modulate the course of IBD, including a positive overall influence. Interestingly, and in contrast to the results on the clinical course of IBD, psychological variables were significantly different between the dietary patterns. The VD IBD patients had lower mental SF-36 scores and a higher level of post-traumatic stress symptoms. We hypothesize that these psychological factors and patient expectations are the main driving factors for the initiation and continuous following of dietary restriction. The alternative explanation, that refraining from meat would lead to stress and anxiety, seems much less likely. Although our cross-sectional data do not allow us to draw conclusions on causality, a study by Michalak et al. 28 supports our hypothesis that psychological factors and expectations affect subsequent dietary restriction. The number of CeD-free individuals who follow a GFD is continuously increasing, 14 but there are no data regarding mood disorders in this subgroup. Our results demonstrate an obvious association of reduced psychological well-being and quality of life with a GFD. All psychosocial variables differed significantly between non-GFD-and GFD-eating patients. It is probable that GFD-eating patients have an even stronger tendency to believing in the effects of their diet than vegetarian patients and thus try to positively influence their disease by modulating food intake. Our findings further support this suggestion, as GFD IBD patients in our study were more prone to try alternative medicine therapies. Greater psychological distress is also associated with more somatic symptoms, 29 which patients might attribute to IBD, prompting them to adjust their dietary habits in an attempt to exert control on their symptoms
Another important aspect related to dietary restriction in general, and specifically the consumption of meat or gluten, is the alteration of microbiota composition. The gut microbiota in vegetarians has been shown to be associated with higher bacterial diversity, 30 with a significantly lower counts of pathobionts Enterobacteriaceae 31 and increased numbers of Prevotella, 18,31 whereas the non-VD, especially the Western diet, has been associated with a greater abundance of Bacteroides 18,21,31 and lower levels of Firmicutes. 21 Furthermore, a GFD in healthy individuals can shift the gut microbiota to fewer bacterial strains that are considered to be more healthy, including Bifidobacteria and Lactobacillus, with lower counts of Escherichia coli and Enterobacteriacea, 32 which are often considered to be rather unhealthy bacteria.
On the other hand, previous studies have shown that patients with IBD have a lower diversity in their gut microbiota, 19, 20 with an increase invasive E. coli, 33 increased Enterobacteriaceae 34 and a reduced proportion of Firmicutes. 20 In our study, the gut microbiota composition in meat-eating IBD patients was significantly different 
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compared to those following a VD or GFD. Our results demonstrated several bacterial changes in regularly meat-eating IBD compared to VD or GFD patients, specifically lower species richness with a dose-response effect in meat-eating CD patients. Interestingly, we could see the opposite finding in UC patients, with greater species richness in patients with a higher frequency of meat consumption. Our study has several limitations. First, due to the cross-sectional analysis, we cannot draw any conclusion on cause and effect.
Dietary habits were self-reported, making them potentially unreliable, which is a limitation that is common to many studies investigating the role of diet in health and disease. Many different food frequency questionnaires exist 35 but, due to the specific nature of the questions that we wanted to ask, we created our own questionnaire. However, our dietary questions were distinctively targeted and easily comprehensible, in contrast to many other dietary interrogations that seek to obtain (semi-) quantitative information.
A further weakness relates to the non-available CeD serology; thus, we had to rely on patient reported-diagnosis of CeD, which may have led to over-or underestimation of the IBD patients following a GFD with genuine concomitant CeD. However, most of our IBD patients were well informed regarding their secondary diagnoses.
It must be considered that GFD represents a rather recent trend in subjects without CeD and the durations of GFDs in our patient population were considerably shorter compared to the durations of VDs (S- Figure 1A and 1B). Therefore, any conclusions regarding the (long-term) impacts of a GFD on the course of the disease have to be drawn with caution.
In conclusion, our study demonstrates a similar prevalence of VDs and a higher percentage of GFDs in IBD patients compared to the general population. We could not observe an association between dietary patterns and the course of IBD, with the exception of lower complication rates in VD CD patients. In contrast, VDs and GFDs were both characterized by adverse psychological scores. Apparently, a significant fraction of IBD patients appear to restrict their diets due to underlying beliefs, expectations or perceptions of beneficial effects on disease course, rather than detectable objective benefits on the course of the disease. Furthermore, we found significant differences in mucosa-associated gut microbiota composition between VD and GFD IBD patients compared with counterparts not restricting their diets.
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